Clinical Trial Update: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for CBP501/Cisplatin/Nivolumab in advanced pancreatic cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CBP501/Cisplatin/Nivolumab

Snippet

Sponsor: CanBas Co. Ltd. | Conditions: Pancreatic Cancer Stage IV | Phase 2 | Status: COMPLETED